Cord blood disorders is speculative, some research has been done in other areas. Any such potential beyond blood and immunological uses is limited by the fact that cord cells are hematopoietic stem cells (which can differentiate only into blood cells), and not pluripotent stem cells (such as embryonic stem cells, which can differentiate into any type of tissue). Cord blood has been studied as a treatment for diabetes. However, apart from blood disorders, the use of cord blood for other diseases is not in routine clinical use and remains a major challenge for the stem cell community. Along with cord blood, Wharton's
Family history (medicine) investigating symptoms or initiating treatment. This is seen particularly in cardiac disease, where a strong family history is considered a significant cardiovascular risk factor. In diseases with a known hereditary component, many otherwise healthy people with a positive family history are tested early, with the aim of an early diagnosis and intervention to prevent the symptoms from developing. This has become accepted in hemochromatosis and various other disorders. Family history (medicine) In medicine, a family history (FH or FHx) consists of information about disorders from which the direct blood relatives of the patient have suffered. Genealogy typically includes very little